"Curelator was created to examine patients' migraine triggers. Patients input different variables (sleep, exercise, and more) to see if there could be individual triggers. We thought that it would be interesting to see if there could be certain variables, such as performing relaxation exercises, which would be protective against the development of headaches," commented Dr. Minen. Elizabeth K. Seng, PhD, Assistant Professor in the Ferkauf Graduate School of Psychology is also involved in the study.
This is an IRB-approved clinical study for adults with migraine or post concussion headaches, which uses Curelator Headache, a digital application that collects information every day about things that may increase or decrease each individual's headaches and migraine attacks. The application is currently available on iPhone and iPad only. Participants are being asked to input data daily for 90 days, with an extension of an additional 90 days if they wish, to see if they can modify their behaviors to try and reduce their headache frequency or intensity. This study will include a specially designed set of relaxation exercises, accessible on an audio tape.
Each day, participants will be asked questions about the amount of time they were able to fully engage with the program, questions about psychologist consultations, and whether they performed the intervention or exercise that, when they first started the study, they said increased their relaxation.
"The ability of Curelator Headache to track, measure and analyze the complex interactions of things that people do in their everyday life is an important aspect of the platform." Said Alec Mian, Ph.D. CEO of Curelator Inc. "In this study, Dr. Minen will examine the potential for behavioral and relaxation protocols to offer a protective effect for migraineurs and people with post concussion headaches and expand our understanding and management of these conditions."
About Curelator Inc.
Curelator Inc. seeks to improve quality of life, clinical health outcomes and lower medical costs in chronic conditions where people experience debilitating episodic attacks, such as migraine, epilepsy, and irritable bowel syndrome using non-pharmaceutical, knowledge-driven technologies.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/curelator-headache-announces-study-with-nyu-langone-medical-center-to-examine-effectiveness-of-protective-behaviors-for-migraineurs-and-post-concussive-headache-patients-300343003.html
SOURCE Curelator Inc.